Zeng, Xinv – Trademark Portfolio

Entity Type: 01

Zeng, Xinv holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include NUQLYN, QIPTUR, and TNMIVO. The owner is based in Jiangxi.

Wenfeng Town, Jishui County,

No. 26, Lanjia Village, Diping Village,

Jiangxi 331699 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

QIPTUR
QIPTUR
Registered 2025
TNMIVO
TNMIVO
Registered 2024
NUQLYN
NUQLYN
Registered 2024

Trademark Classifications

Zeng, Xinv's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Zeng, Xinv have?

Zeng, Xinv has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Zeng, Xinv file in?

Zeng, Xinv files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Zeng, Xinv's most well-known trademarks?

Zeng, Xinv's registered trademark portfolio includes well-known marks such as NUQLYN, QIPTUR, and TNMIVO. These are among 3 currently registered trademarks in the portfolio.

What is Zeng, Xinv's trademark registration success rate?

Zeng, Xinv has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.